Acne Treatment Market Size Is Projected to Hit USD 14.44 Billion at a 4.6% CAGR by 2032
Research Reports
Aug 18, 2023
Acne Treatment Market Research Report Information by Acne Type (Moderate, Mild, Moderate to Severe), Treatment (Medication, Therapeutic Devices), Drug Type (OTC, Prescription), Route of Administration (Topical, Oral, Injectable), End User (Hospitals & Clinics, Specialty Centers) and Region (Americas, Europe, Asia-Pacific, and Rest of the World) – Forecast till 2032
According to MRFR analysis, the global Acne Treatment Market is expected to register a CAGR of 4.6 % from 2023 to 2032 and hold a value of over USD 14.44 billion by 2032.
The acne treatment market is a dynamic and rapidly evolving sector, driven by both the increasing prevalence of acne and advancements in dermatological research and technology. This article explores the trends and innovations shaping the acne treatment market, highlighting key players, emerging therapies, and the factors driving market growth.
Growing desire for minimally invasive cosmetic treatment methods, increased sedentary lifestyles and bad eating patterns, and the incidence of acne vulgaris in teens and adults are some of the factors that have fueled demand and driven market expansion. However obstacles to the market’s expansion include safety concerns with the acne treatment solutions.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/5675
In March 2020, the WHO labeled COVID-19 a pandemic due to the increasing number of breakouts in various nations across the world. In order to stop the virus from spreading, a public health emergency was proclaimed and precautions were distributed. Now, the rapid proliferation of COVID-19 is having a significant influence on several businesses and industries. COVID-19 has compelled healthcare organizations to adopt a variety of non-traditional business structures.
Segmentation
Based on the kind of acne, the therapy used, the medication type, the administration method, and the end user, the acne treatment market has been segmented.
Acne types have been divided into three categories: mild acne, moderate acne, and severe acne. With a share of 43.72% in 2019, the sector for mild acne is expected to grow at the quickest rate.
Moderate acne is classified as having more whiteheads, blackheads, and papules than mild acne. When there are several huge, uncomfortable papules, pustules, and nodules or cysts, it is considered that severe acne has developed. The market for acne treatments is expanding as a result of rising acne prevalence and growing concern over face hygiene.
The rising incidence of skin problems, particularly acne, is a major factor driving the expansion of the market for acne treatments in hospitals and clinics. According to the American Academy of Dermatology Association, acne affects about 85% of teens at some time throughout their adolescence. In the US, acne affects about 50 million individuals overall. In the end, hospitals and clinics are involved in all of these situations to cure the acne.
Key Players
Some of the top market players are GlaxoSmithKline plc., Almirall S.A., Galderma Laboratories, Hoffman La Roche Ltd, Bausch Health Companies Inc, Leo Pharma A/S, Johnson & Johnson Services Inc, Teva Pharmaceutical Industries Ltd, Candela Corporation and Vyne Therapeutics Inc
Regional Analysis
Americas dominated the market for acne treatments in 2019 and is expected to do so again during the study period. This can be ascribed to the region’s high prevalence of acne and other skin conditions, product introductions, and technological development. According to the American Academy of Dermatology Association, acne affects around 85% of teens at some time throughout their adolescence. In the US, acne affects about 50 million individuals overall.
Browse In-depth Market Research Report (153 Pages) on Acne Treatments: https://www.marketresearchfuture.com/reports/acne-treatment-market-5675
The market for acne treatment in the area is expanding as a result of key companies’ attention to the development and marketing of innovative products. The Italian pharmaceutical firm CassiopeaSpA announced in August 2020 that its Winlevi (clascoterone cream 1%) for the treatment of acne has received US FDA clearance. Similar to this, the Swiss pharmaceutical company Galderma has unveiled its topical retinoid trifarotene 0.005%. Galderma specializes in dermatological treatments and skincare products. The US FDA has authorized AKLIEF for the treatment of acne vulgaris. Companies may improve their position in the European market by using these organic growth tactics.
Asia-Pacific is expected to see the fastest growth. This is because there are more pharmaceutical businesses present, there is a high frequency of acne, and there are more government initiatives. The government’s numerous efforts to assist the healthcare system are also promoting regional market expansion. Also, as middle-class families in Asia, which make up a significant portion of the population, have more discretionary income, they are spending more on their health, which is boosting the demand for acne treatments there.
Discover More Research Reports on Healthcare Industry by Market Research Future:
Cardiac Pacemaker Market Research Report – Forecast till 2030
Home Healthcare Market Research Report – Forecast to 2030
Intra-Cranial Pressure Monitor Market Research Report- Forecast To 2030
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Follow Us: LinkedIn | Twitter
Contact Information:
Market Research Future (Part of Wantstats Research and Media Private Limited) 99 Hudson Street, 5Th Floor New York, NY 10013 United States of America +1 628 258 0071 (US) +44 2035 002 764 (UK) Email: sales@marketresearchfuture.com Website: https://www.marketresearchfuture.com
Tags:
Wire, Extended Distribution, Research Newswire, English